nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Artekin: an affordable antimalarial
|
Bonn, Dorothy |
|
2004 |
4 |
5 |
p. 256- 1 p. |
artikel |
2 |
Development of genetically modified mosquitoes in Africa
|
Mshinda, Hassan |
|
2004 |
4 |
5 |
p. 264-265 2 p. |
artikel |
3 |
Egypt conquers lymphatic filariasis
|
Dean, Malcolm |
|
2004 |
4 |
5 |
p. 260- 1 p. |
artikel |
4 |
FDA plans warning labels for condoms
|
Morris, Kelly |
|
2004 |
4 |
5 |
p. 257- 1 p. |
artikel |
5 |
FDA to withdraw approval for enrofloxacin
|
Nelson, Roxanne |
|
2004 |
4 |
5 |
p. 258- 1 p. |
artikel |
6 |
Infections related to the ingestion of seafood. Part II: parasitic infections and food safety
|
Butt, Adeel A |
|
2004 |
4 |
5 |
p. 294-300 7 p. |
artikel |
7 |
Infectious disease surveillance update
|
Das, Pam |
|
2004 |
4 |
5 |
p. 259- 1 p. |
artikel |
8 |
Influenza: time to come to grips with the avian dimension
|
Melville, DS |
|
2004 |
4 |
5 |
p. 261-262 2 p. |
artikel |
9 |
Injecting reason
|
The Lancet Infectious Diseases, |
|
2004 |
4 |
5 |
p. 253- 1 p. |
artikel |
10 |
Is chronic rhinosinusitus a fungal problem?
|
Senior, Kathryn |
|
2004 |
4 |
5 |
p. 257- 1 p. |
artikel |
11 |
Marc Struelens-President of the European Society of Clinical Microbiology and Infectious Diseases
|
Das, Pam |
|
2004 |
4 |
5 |
p. 308-311 4 p. |
artikel |
12 |
Media Watch
|
Larkin, Marilynn |
|
2004 |
4 |
5 |
p. 312-313 2 p. |
artikel |
13 |
Media Watch
|
Gilbert, Jeff |
|
2004 |
4 |
5 |
p. 312- 1 p. |
artikel |
14 |
Members only for EU health care
|
Shetty, Priya |
|
2004 |
4 |
5 |
p. 254- 1 p. |
artikel |
15 |
Microbicides strike an upbeat note
|
Bonn, Dorothy |
|
2004 |
4 |
5 |
p. 255- 1 p. |
artikel |
16 |
Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia?
|
Costa, Silvia F |
|
2004 |
4 |
5 |
p. 278-286 9 p. |
artikel |
17 |
Must be something in the water
|
Dixon, Bernard |
|
2004 |
4 |
5 |
p. 314- 1 p. |
artikel |
18 |
New human coronavirus isolated
|
Ahmad, Khabir |
|
2004 |
4 |
5 |
p. 255- 1 p. |
artikel |
19 |
Polio eradication—rethinking the endpoint of the end game
|
Khuri-Bulos, Najwa |
|
2004 |
4 |
5 |
p. 262-263 2 p. |
artikel |
20 |
Rationale for evaluating North America's first medically supervised safer-injecting facility
|
Wood, Evan |
|
2004 |
4 |
5 |
p. 301-306 6 p. |
artikel |
21 |
Slow progress worries Stop TB Partnership
|
Sharma, Dinesh C |
|
2004 |
4 |
5 |
p. 256- 1 p. |
artikel |
22 |
Transmission of HIV-2: another perspective
|
Mota-Miranda, António |
|
2004 |
4 |
5 |
p. 265-266 2 p. |
artikel |
23 |
Tuberculosis in New York city: recent lessons and a look ahead
|
Paolo Jr, William F |
|
2004 |
4 |
5 |
p. 287-293 7 p. |
artikel |
24 |
USA establishes advisory board for “dual use” research
|
Quirk, Mary |
|
2004 |
4 |
5 |
p. 258- 1 p. |
artikel |
25 |
Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level
|
Bates, Imelda |
|
2004 |
4 |
5 |
p. 267-277 11 p. |
artikel |